Literature DB >> 2182729

Production of cytokines by peripheral blood monocytes/macrophages infected with human immunodeficiency virus type 1 (HIV-1).

J M Molina1, R Schindler, R Ferriani, M Sakaguchi, E Vannier, C A Dinarello, J E Groopman.   

Abstract

The study of monocyte/macrophage functions after human immunodeficiency virus type 1 (HIV-1) infection may help in understanding the pathogenesis of AIDS. The production of four cytokines, tumor necrosis factor alpha (TNF alpha), interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and granulocyte-macrophage colony-stimulating factor (GM-CSF), by peripheral blood monocytes/macrophages was evaluated after in vitro infection with HIV-1. HIV-1 infection of these monocytes/macrophages did not result in release of any of these cytokines. Similarly, treatment of uninfected cells with purified recombinant HIV-1 envelope protein did not result in cytokine production. After stimulation with endotoxin or endotoxin plus interferon-gamma, HIV-1-infected monocytes/macrophages produced amounts of TNF alpha, IL-6, GM-CSF, and IL-1 beta comparable to that of uninfected cells. HIV-1 infection does not appear to induce or alter cytokine production by mononuclear phagocytes, which retain the capacity to produce these cytokines after endotoxin stimulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2182729     DOI: 10.1093/infdis/161.5.888

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders.

Authors:  R A Nolan; R Muir; K Runner; E K Haddad; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2018-12-05       Impact factor: 4.147

Review 2.  Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.

Authors:  K J Connolly; S M Hammer
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

3.  Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs.

Authors:  Divya Prakash Gnanadhas; Prasanta K Dash; Brady Sillman; Aditya N Bade; Zhiyi Lin; Diana L Palandri; Nagsen Gautam; Yazen Alnouti; Harris A Gelbard; JoEllyn McMillan; R Lee Mosley; Benson Edagwa; Howard E Gendelman; Santhi Gorantla
Journal:  J Clin Invest       Date:  2017-01-30       Impact factor: 14.808

4.  Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.

Authors:  Walter Royal; Li Zhang; Ming Guo; Odell Jones; Harry Davis; Joseph L Bryant
Journal:  J Neuroimmunol       Date:  2012-04-12       Impact factor: 3.478

5.  Expression of IL-10, IL-4 and interferon-gamma in unstimulated and mitogen-stimulated peripheral blood lymphocytes from HIV-seropositive patients.

Authors:  F Diaz-Mitoma; A Kumar; S Karimi; M Kryworuchko; M P Daftarian; W D Creery; L G Filion; W Cameron
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

6.  Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans.

Authors:  S M Levitz; A Tabuni; H Kornfeld; C C Reardon; D T Golenbock
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

7.  Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages.

Authors:  P D Smith; S S Saini; M Raffeld; J F Manischewitz; S M Wahl
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

Review 8.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

9.  Evidence that Lo's mycoplasma (Mycoplasma fermentans incognitus) is not a unique strain among Mycoplasma fermentans strains.

Authors:  T Sasaki; Y Sasaki; M Kita; K Suzuki; H Watanabe; M Honda
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

10.  Elevated serum levels of IL-8 in patients with HIV infection.

Authors:  T Matsumoto; T Miike; R P Nelson; W L Trudeau; R F Lockey; J Yodoi
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.